Logo image of ATXS

ASTRIA THERAPEUTICS INC (ATXS) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ATXS - US04635X1028 - Common Stock

12.83 USD
+0.12 (+0.94%)
Last: 12/19/2025, 8:00:01 PM
12.7384 USD
-0.09 (-0.71%)
After Hours: 12/19/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ATXS revenue by date.ATXS revenue by date.
500K
-100.00%
8.74M3.57M
-59.15%
4.264M
19.44%
60.85M
1,327.06%
241.65M
297.12%
448.51M
85.60%
627.47M
39.90%
792.02M
26.22%
EBITDA
YoY % growth
ATXS ebitda by date.ATXS ebitda by date.
-31.46M
-46.80%
-35.16M
-11.76%
-26.79M
23.81%
N/A
2.02%
N/A
-3.09%
-35.904M
-32.68%
-197.982M
-451.42%
-52.938M
73.26%
-71.298M
-34.68%
-114.24M
-60.23%
-162.282M
-42.05%
-182.784M
-12.63%
-200.226M
-9.54%
-209.712M
-4.74%
N/AN/AN/AN/A
EBIT
YoY % growth
ATXS ebit by date.ATXS ebit by date.
-31.66M
-46.03%
-35.56M
-12.32%
-27.09M
23.82%
-27.475M
2.66%
-28.27M
-2.73%
-38.148M
-38.21%
-197.657M
-420.78%
-54M
72.56%
-80.417M
-26.79%
-115.558M
-64.46%
-142.552M
-27.78%
-158.677M
-11.31%
-162.414M
-2.36%
-140.319M
13.60%
-3.929M
97.20%
110.39M
2,909.35%
232.86M
110.94%
346.65M
48.87%
Operating Margin
ATXS operating margin by date.ATXS operating margin by date.
N/AN/A-5,418.00%N/AN/AN/AN/AN/AN/AN/A-1,631.03%-4,444.73%-3,808.95%-230.60%-1.63%24.61%37.11%43.77%
EPS
YoY % growth
ATXS eps by date.ATXS eps by date.
N/A-133.80
42.05%
-76.80
42.60%
-30.15
46.09%
-14.78
65.94%
-11.51
13.62%
-39.19
-17.49%
-3.58
74.63%
-2.32
33.33%
-1.69
40.91%
-2.20
-53.66%
-2.27
-3.42%
-2.01
11.72%
-1.98
1.53%
-0.83
58.18%
-0.95
-14.81%
1.13
218.82%
2.29
103.17%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.57
-182.61%
-0.59
-1.25%
-0.60
-5.22%
-0.61
-11.55%
-0.65
-14.50%
-0.79
-34.26%
-0.65
-7.99%
-0.69
-11.89%
-0.72
-11.90%
Revenue
Q2Q % growth
3.06M1.02M1.02M1.02M
44.48%
510K
-83.33%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-46.92M
-52.82%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-34.267M
-15.80%
-36.887M
0.29%
-37.358M
-4.29%
-37.867M
-11.03%
-40.538M
-18.30%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.55
-30.95%
-0.40-0.15-38.11%
Q2 2025
Q2Q % growth
-0.57
-32.56%
-0.600.034.64%
Q1 2025
Q2Q % growth
-0.58
-52.63%
-0.49-0.09-18.75%
Q4 2024
Q2Q % growth
-0.20
78.72%
-0.460.2656.57%
Q3 2024
Q2Q % growth
-0.42
33.33%
-0.430.012.33%
Q2 2024
Q2Q % growth
-0.43
4.44%
-0.39-0.04-9.50%
Q1 2024
Q2Q % growth
-0.38
5.00%
-0.37-0.01-2.35%
Q4 2023
Q2Q % growth
-0.94
-30.56%
-0.80-0.14-18.12%
Q3 2023
Q2Q % growth
-0.63
27.59%
-0.50-0.13-27.09%
Q2 2023
Q2Q % growth
-0.45
47.67%
-0.500.059.44%
Q1 2023
Q2Q % growth
-0.40
66.10%
-0.560.1628.94%
Q4 2022
Q2Q % growth
-0.72
93.45%
-0.730.010.81%
Q3 2022
Q2Q % growth
-0.87
-42.62%
-0.940.077.09%
Q2 2022
Q2Q % growth
-0.86
31.75%
-1.040.1816.93%
Q1 2022
Q2Q % growth
-1.18
18.06%
-0.74-0.44-58.91%
Q4 2021
Q2Q % growth
-11.00
-316.67%
-0.67-10.33-1,533.99%
Q3 2021
Q2Q % growth
-0.61
81.85%
-0.790.1822.58%
Q2 2021
Q2Q % growth
-1.26
60.38%
-1.860.6032.13%
Q1 2021
Q2Q % growth
-1.44
52.00%
-0.94-0.50-53.46%
Q4 2020
Q2Q % growth
-2.64
20.00%
-2.26-0.38-16.59%
Q3 2020
Q2Q % growth
-3.36 -3.12-0.24-7.65%
Q2 2020
Q2Q % growth
-3.18
14.52%
-2.78-0.40-14.20%
Q1 2020
Q2Q % growth
-3.00
19.35%
-2.51-0.49-19.56%
Q4 2019
Q2Q % growth
-3.30 -3.760.4612.32%
Q3 2019
Q2Q % growth
-3.36 -3.890.5313.72%
Q2 2019
Q2Q % growth
-3.72 -3.71-0.01-0.19%
Q1 2019
Q2Q % growth
-3.72 -4.250.5312.54%
ATXS Yearly EPS VS EstimatesATXS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -50 -100 -150 -200
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
706K 10.88M-10.174M-93.51%
ATXS Yearly Revenue VS EstimatesATXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.51% -0.31% -3.64% -1.27%
Revenue0% 0% -37.3% -37.3%